[Failure of an anti-CGRP monoclonal antibody in the treatment of migraine. Is it worthwhile trying another one?] [PDF]
Rev Neurol, 2022 López-Moreno Y +3 more
europepmc +1 more source
[Successful Management of Wearing-off effect with Eptinezumab: Lessons from a case with Chronic Migraine Refractory to Two Subcutaneous CGRP Antibodies]. [PDF]
Rev NeurolPolanco Fernández M +4 more
europepmc +1 more source
[Adaptation of headache units in Andalusia to the COVID-19 pandemic. Analysis of the Andalusian Neurology Society's Headache Study Group]. [PDF]
Rev Neurol, 2022 Lamas-Pérez R +5 more
europepmc +1 more source
Anticuerpos monoclonales en el tratamiento del cáncer
, 2016 En la actualidad el cáncer es una patología muy prevalente, pero gracias al conocimiento de su biología se ha conseguido desarrollar nuevos fármacos, entre los que destacan los anticuerpos monoclonales (mabs). Estos son proteínas inmunitarias producidas por ingeniería genética, las cuales se van a unir a ciertas dianas presentes en la célula tumoral y ...
openaire +1 more source
Recommendations on vaccination in children and adolescents with inborn errors of immunity according to the expanded Colombian immunization program [PDF]
BiomedicaCortés-Marín N +4 more
europepmc +1 more source
[Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment]. [PDF]
Enferm Infecc Microbiol Clin, 2022 Pinargote-Celorio H +13 more
europepmc +1 more source
Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab. [PDF]
Rev NeurolGarcía-Estévez DA +5 more
europepmc +1 more source
[Classic presentation of neuromyelitis optica: clinical case and review of the literature]. [PDF]
Rev Med Inst Mex Seguro SocNúñez-Martínez FJ +5 more
europepmc +1 more source
Farmacogenética del cáncer colorrectal en un hospital terciario de Valencia. [PDF]
Adv Lab MedComes-Raga A +4 more
europepmc +1 more source